Niveau de preuve du suivi thérapeutique pharmacologique du posaconazole
Therapie, 66 2 (2011) 115-122
Published online: 2011-06-06
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Cerebral diffusion of posaconazole in an experimental model of disseminated scedosporiosis
Bénédicte Lelièvre, Charlotte Godon, Pierre Legras, Jérémie Riou, David Ternant and Jean-Philippe BoucharaBiomedicine & Pharmacotherapy 194 118918 (2026)
https://doi.org/10.1016/j.biopha.2025.118918
Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic Fibrosis
Manon Launay, Antoine Roux, Laurence Beaumont, Benoit Douvry, Lucien Lecuyer, Emmanuel Douez, Clément Picard, Dominique Grenet, Vincent Jullien, Véronique Boussaud, Romain Guillemain and Eliane M. BillaudAntimicrobial Agents and Chemotherapy 62 (3) (2018)
https://doi.org/10.1128/AAC.02061-17
Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies
C. Boglione-Kerrien, S. Picard, C. Tron, et al.Journal of Cancer Research and Clinical Oncology (2017)
https://doi.org/10.1007/s00432-017-2523-2
Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice
Magali Bourdelin, Frédéric Grenouillet, Etienne Daguindau, et al.Medical Mycology 52 (7) 728 (2014)
https://doi.org/10.1093/mmy/myu042